Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P160017/S136

Simplera Sync Sensor

Medtronic MiniMed, Inc. · Decision date Mar 19, 2026

FDA DECISIONP160017/S136

What did the FDA decide?

FDA records P160017/S136 as a supplement to PMA P160017, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Mar 19, 2026.

FDA approval order statement

to add the Medtronic Northridge facility as an additional site for conducting post-sterilization quality testing for the Simplera Sync sensor. The Simplera Sync sensor is a component of the MiniMed 780G System
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Clinical Chemistry
Decision date
Mar 19, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P160017/S136
Regulatory pathway
PMA supplement
Product code
OZP
Decision code
OK30
Decision date
Mar 19, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automated insulin dosing device system, single hormonal control.

Product code
OZP
FDA device class
3

For the original device and its historical approval scope, see PMA P160017. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P160017 · Original PMA

    MiniMed 670G System

  2. P160017/S130 · Related supplement

    MiniMed 670G System; MiniMed 770G System; MiniMed 780G System

  3. P160017/S131 · Related supplement

    MiniMed 670G system MiniMed 770G system MiniMed 780G system

  4. P160017/S136 received

    Application receipt date recorded by FDA.

  5. P160017/S136 · FDA decision

    30-Day Notice

  6. P160017/S137 · Related supplement

    Simplera and Simplera Sync

  7. P160017/S138 · Related supplement

    Simplera Sync; Guardian Sensor (3) Transfer to MPROC; MiniMed 780G System with G4S

  8. P160017/S139 · Related supplement

    MiniMed 770G Insulin Pump; MiniMed 780G Insulin Pump

Timeline entries are records held by MedtechLedger for P160017. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P160017

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic MiniMed, Inc.PMA approvalSep 28, 2016FDA
Medtronic MiniMed, Inc.PMA supplementAug 20, 2025FDA
Medtronic MiniMed, Inc.PMA supplementAug 25, 2025FDA
Medtronic MiniMed, Inc.PMA supplementAug 29, 2025FDA
Medtronic MiniMed, Inc.PMA supplementSep 12, 2025FDA
Medtronic MiniMed, Inc.PMA supplementOct 2, 2025FDA
Medtronic MiniMed, Inc.PMA supplementOct 9, 2025FDA
Medtronic MiniMed, Inc.PMA supplementOct 16, 2025FDA
Medtronic MiniMed, Inc.PMA supplementDec 5, 2025FDA
Medtronic MiniMed, Inc.PMA supplementDec 8, 2025FDA
Medtronic MiniMed, Inc.PMA supplementDec 10, 2025FDA
Medtronic MiniMed, Inc.PMA supplementDec 11, 2025FDA
Medtronic MiniMed, Inc.PMA supplementDec 18, 2025FDA
Medtronic MiniMed, Inc.PMA supplementMay 26, 2026FDA
Medtronic MiniMed, Inc.PMA supplementJun 12, 2026FDA
Medtronic MiniMed, Inc.PMA supplementJul 21, 2026FDA
Medtronic MiniMed, Inc.PMA supplementAug 5, 2026FDA
Medtronic MiniMed, Inc.PMA supplementSep 29, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic MiniMed, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
18000 Devonshire St., Northridge, CA, 91325

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records